Intervention group | P | Control group | P | Intervention group D (T0-T1) | Control group D (T0-T1) | P | |||
---|---|---|---|---|---|---|---|---|---|
T0 | T1 | T0 | T1 | ||||||
Initial SpO2, % | 96 ± 2 | 96 ± 2 | 0.137 | 96 ± 1 | 95 ± 1 | 0.032 | − 0.38 ± 0.87 | 0.75 ± 0.90 | 0.007 |
Minimal SpO2, % | 93 ± 2 | 93 ± 2 | 0.025 | 93 ± 2 | 92 ± 1 | 0.01 | − 0.62 ± 0.87 | 0.83 ± 0.94 | 0.001 |
End SpO2, % | 95 ± 3 | 95 ± 2 | 0.861 | 95 ± 1 | 94 ± 1 | 0.005 | − 0.08 ± 1.55 | 0.92 ± 0.90 | 0.065 |
IC, % predicted | 90 ± 22 | 94 ± 22 | 0.239 | 96 ± 26 | 93 ± 24 | 0.472 | − 4.69 ± 13.64 | 2.85 ± 13.26 | 0.175 |
FVC, % predicted | 102 ± 13 | 103 ± 16 | 0.522 | 96 ± 28 | 98 ± 29 | 0.483 | − 1.76 ± 9.65 | − 1.55 ± 7.40 | 0.952 |
FEV1, % predicted | 85 ± 22 | 91 ± 19 | 0.173 | 77 ± 29 | 74 ± 30 | 0.129 | − 6.46 ± 16.08 | 2.86 ± 6.03 | 0.072 |
FEV1/ FVC, % | 65 ± 14 | 70 ± 12 | 0.145 | 62 ± 13 | 59 ± 13 | 0.006 | − 4.09 ± 9.45 | 2.92 ± 2.96 | 0.022 |
MVV, % predicted | 91 ± 26 | 102 ± 25 | 0.024 | 81 ± 31 | 81 ± 34 | 0.935 | − 10.65 ± 14.86 | 0.30 ± 12.38 | 0.058 |
mMRC score | 1 (1, 1) | 0 (0, 0.5) | 0.002 | 0.5 (0, 1.75) | 0 (0, 1) | 0.157 | 1 (0.5, 1) | 0 (0, 0) | 0.003 |